|
US1001159A
(en)
|
1910-07-25 |
1911-08-22 |
Elizabeth Nielsen |
Skirt-gage.
|
|
GB1472257A
(en)
|
1973-09-10 |
1977-05-04 |
Christiaens Sa A |
Derivative of 4-hydroxy-5-azacoumarin
|
|
US4866182A
(en)
|
1988-02-18 |
1989-09-12 |
Merrell Dow Pharmaceuticals Inc. |
Cardiotonic alkanoyl and aroyl oxazolones
|
|
US5338740A
(en)
|
1993-07-13 |
1994-08-16 |
Pfizer Inc. |
Angiotensin II receptor antagonists
|
|
JP3795305B2
(ja)
|
1999-07-19 |
2006-07-12 |
田辺製薬株式会社 |
医薬組成物
|
|
CA2438991C
(en)
|
2001-02-21 |
2010-08-17 |
Nps Pharmaceuticals, Inc. |
Heteropolycyclic compounds and their use as metabotropic glutamate receptor antagonists
|
|
EA006154B1
(ru)
|
2001-03-28 |
2005-10-27 |
Пфайзер Инк. |
N-фенпропилциклопентил-замещенные производные глутарамида в качестве nep ингибиторов при fsad
|
|
CA2459224C
(en)
|
2001-09-03 |
2012-05-08 |
Takeda Chemical Industries, Ltd. |
1,3-benzothiazinone derivatives and the use thereof
|
|
JP2005170790A
(ja)
|
2002-01-09 |
2005-06-30 |
Ajinomoto Co Inc |
Ｎ−アルキルスルフォニル置換アミド誘導体
|
|
JP2005162612A
(ja)
|
2002-01-09 |
2005-06-23 |
Ajinomoto Co Inc |
アシルスルホンアミド誘導体
|
|
ES2334990T3
(es)
*
|
2002-02-14 |
2010-03-18 |
Pharmacia Corporation |
Piridinonas sustituidas como moduladores de p38 map quinasa.
|
|
US20040147561A1
(en)
*
|
2002-12-27 |
2004-07-29 |
Wenge Zhong |
Pyrid-2-one derivatives and methods of use
|
|
US20090048301A1
(en)
|
2003-07-09 |
2009-02-19 |
Imclone Systems Incorporated |
Heterocyclic compounds and their use as anticancer agents
|
|
US20060004001A1
(en)
|
2004-02-27 |
2006-01-05 |
Merz Pharma Gmbh & Co., Kgaa |
Tetrahydroquinolones and their use as modulators of metabotropic glutamate receptors
|
|
PE20060285A1
(es)
*
|
2004-03-30 |
2006-05-08 |
Aventis Pharma Inc |
Piridonas sustituidas como inhibidores de pol(adp-ribosa)-polimerasa (parp)
|
|
CN1960969B
(zh)
|
2004-04-01 |
2012-03-28 |
伊莱利利公司 |
组胺h3受体药物、其制备方法及治疗用途
|
|
JP5020073B2
(ja)
|
2004-06-18 |
2012-09-05 |
ミレニアム ファーマシューティカルズ インク． |
第Ｘａ因子阻害剤
|
|
WO2006019833A1
(en)
|
2004-07-26 |
2006-02-23 |
Eli Lilly And Company |
Oxazole derivatives as histamine h3 receptor agents, preparation and therapeutic uses
|
|
EP1655283A1
(en)
|
2004-11-08 |
2006-05-10 |
Evotec OAI AG |
11beta-HSD1 Inhibitors
|
|
WO2006123165A2
(en)
*
|
2005-05-19 |
2006-11-23 |
Astex Therapeutics Limited |
Pyrimidine derivatives as hsp90 inhibitors
|
|
WO2007023242A1
(en)
|
2005-08-24 |
2007-03-01 |
Merz Pharma Gmbh & Co. Kgaa |
Tetrahydroquinolinones and their use as modulators of metabotropic glutamate receptors
|
|
DK1984353T3
(en)
|
2006-01-23 |
2016-03-14 |
Amgen Inc |
Aurorakinasemodulatorer and method of use
|
|
JP2007314516A
(ja)
|
2006-04-25 |
2007-12-06 |
Daiichi Sankyo Co Ltd |
２以上の置換基を有するベンゼン化合物を含有する医薬
|
|
AU2007281212B8
(en)
|
2006-08-03 |
2013-02-28 |
Trustees Of Tufts College |
Non-flushing niacin analogues, and methods of use thereof
|
|
EP2099768A2
(en)
|
2006-08-04 |
2009-09-16 |
Praecis Pharmaceuticals Incorporated |
Agonists of the sphingosine-1-phosphate receptor
|
|
EP1894924A1
(en)
|
2006-08-29 |
2008-03-05 |
Phenex Pharmaceuticals AG |
Heterocyclic FXR binding compounds
|
|
CN101547694A
(zh)
|
2006-12-01 |
2009-09-30 |
诺瓦提斯公司 |
用于促进生理性心脏肥大的蛋白酪氨酸磷酸酶抑制剂
|
|
EP2142547A1
(en)
|
2007-03-28 |
2010-01-13 |
NeuroSearch A/S |
Purinyl derivatives and their use as potassium channel modulators
|
|
EP2674417A3
(en)
*
|
2007-11-21 |
2014-04-09 |
Decode Genetics EHF |
Biaryl PDE4 inhibitors for treating inflammation
|
|
EP2254563A2
(en)
|
2008-01-25 |
2010-12-01 |
Torrent Pharmaceuticals Ltd. |
Pharmaceutical combinations comprising specified age breaker and further drugs, i.a. antihypertensive drugs, antidiabetic drugs etc
|
|
AU2009233711B2
(en)
|
2008-04-09 |
2015-02-12 |
Infinity Pharmaceuticals, Inc |
Inhibitors of fatty acid amide hydrolase
|
|
AU2009253046A1
(en)
|
2008-05-30 |
2009-12-03 |
Foster Wheeler Energia Oy |
Method of and system for generating power by oxyfuel combustion
|
|
WO2010002933A1
(en)
|
2008-06-30 |
2010-01-07 |
Cylene Pharmaceuticals, Inc. |
Oxindole compounds
|
|
JP5535931B2
(ja)
|
2008-10-27 |
2014-07-02 |
武田薬品工業株式会社 |
二環性化合物
|
|
CN102203117A
(zh)
*
|
2008-11-04 |
2011-09-28 |
安科治疗公司 |
Apj受体化合物
|
|
RU2012116207A
(ru)
|
2009-09-24 |
2013-10-27 |
Ф.Хоффманн-Ля Рош Аг |
Производные индола в качестве модуляторов crac
|
|
AU2010299928A1
(en)
|
2009-09-24 |
2012-02-02 |
F. Hoffmann-La Roche Ag |
Heterocyclic antiviral compounds
|
|
WO2011062955A2
(en)
|
2009-11-18 |
2011-05-26 |
University Of Massachusetts |
Compounds for modulating tlr2
|
|
CA2783801A1
(en)
|
2009-12-18 |
2011-06-23 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
CN102241621A
(zh)
|
2010-05-11 |
2011-11-16 |
江苏恒瑞医药股份有限公司 |
5,5-双取代-2-亚氨基吡咯烷类衍生物、其制备方法及其在医药上的应用
|
|
WO2011148956A1
(ja)
|
2010-05-24 |
2011-12-01 |
トーアエイヨー株式会社 |
縮合イミダゾール誘導体
|
|
WO2012040532A1
(en)
*
|
2010-09-24 |
2012-03-29 |
Bristol-Myers Squibb Company |
Substituted oxadiazole compounds and their use as s1p1 agonists
|
|
JPWO2012074022A1
(ja)
|
2010-12-01 |
2014-05-19 |
旭硝子株式会社 |
イリジウムカチオン錯体および発光組成物
|
|
JP2014514257A
(ja)
|
2011-03-03 |
2014-06-19 |
ユニバーシテーテ デス ザールランデス |
選択的１７ベータ−ヒドロキシステロイドデヒドロゲナーゼ２型阻害剤としてのビアリール誘導体
|
|
WO2012142308A1
(en)
|
2011-04-13 |
2012-10-18 |
Activesite Pharmaceuticals, Inc. |
Prodrugs of inhibitors of plasma kallikrein
|
|
EP2709609B1
(en)
|
2011-05-17 |
2017-10-04 |
Shionogi & Co., Ltd. |
Heterocyclic compounds
|
|
BR112014015553B1
(pt)
|
2011-12-23 |
2020-02-27 |
Basf Se |
Compostos de isotiazolina, método de preparação de compostos, composição agrícola ou veterinária, usos de um composto e método para proteger plantas
|
|
US9399638B2
(en)
*
|
2012-05-02 |
2016-07-26 |
Lupin Limited |
Substituted pyridine compounds as CRAC modulators
|
|
BR112014027133A2
(pt)
|
2012-05-09 |
2017-06-27 |
Basf Se |
compostos, composição agrícola ou veterinária, método para o controle das pragas de invertebrados, material de propagação dos vegetais e método para o tratamento ou proteção de um animal.
|
|
WO2013184202A1
(en)
|
2012-06-08 |
2013-12-12 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Fbxo3 inhibitors
|
|
US20160008339A1
(en)
|
2012-07-02 |
2016-01-14 |
Max-Delbruck-Centrum Fur Molekulare Medizin |
Psoralen derivatives for preventing or treating heart failure or cardiac hypertrophy
|
|
CN103570625A
(zh)
|
2012-07-19 |
2014-02-12 |
南京英派药业有限公司 |
N-(3-杂芳基芳基)-4-芳基芳基甲酰胺和类似物作为Hedgehog通路抑制剂及其应用
|
|
US20140073634A1
(en)
|
2012-08-24 |
2014-03-13 |
Institute For Applied Cancer Science/The University of Texas MD Anderson Cancer Center |
Heterocyclic modulators of hif activity for treatment of disease
|
|
ES2623528T3
(es)
*
|
2012-09-21 |
2017-07-11 |
Sanofi |
Derivados de amida de ácido benzoimidazolcarboxílico para tratar enfermedades metabólicas o cardiovasculares
|
|
WO2014062938A1
(en)
|
2012-10-19 |
2014-04-24 |
Bristol-Myers Squibb Company |
Rory modulators
|
|
AU2014228822A1
(en)
|
2013-03-15 |
2015-10-01 |
Memorial Sloan-Kettering Cancer Center |
HSP90-targeted cardiac imaging and therapy
|
|
WO2015017305A1
(en)
|
2013-07-31 |
2015-02-05 |
Merck Sharp & Dohme Corp |
Inhibitors of the renal outer medullary potassium channel
|
|
JP6199197B2
(ja)
|
2014-02-07 |
2017-09-20 |
花王株式会社 |
ポリオキシアルキレンアルキルエーテルカルボン酸塩の製造方法
|
|
JP2017071553A
(ja)
|
2014-02-25 |
2017-04-13 |
味の素株式会社 |
ヘテロ原子−メチレン−ヘテロ環構造を有する新規化合物
|
|
AU2015233558A1
(en)
|
2014-03-20 |
2016-09-01 |
Bayer Pharma Aktiengesellschaft |
Novel compounds
|
|
JP6552061B2
(ja)
|
2014-06-10 |
2019-07-31 |
サンフォード−バーンハム メディカル リサーチ インスティテュート |
代謝型グルタミン酸受容体の負のアロステリックモジュレーター（ｎａｍｓ）とその使用
|
|
AU2016263564B2
(en)
|
2015-05-20 |
2019-12-05 |
Amgen Inc. |
Triazole agonists of the APJ receptor
|
|
CA2988147C
(en)
|
2015-06-03 |
2023-06-13 |
Bristol-Myers Squibb Company |
4-hydroxy-3-(heteroaryl)pyridine-2-one apj agonists for use in the treatment of cardiovascular disorders
|
|
KR101711744B1
(ko)
|
2015-07-16 |
2017-03-02 |
경희대학교 산학협력단 |
옥사디아졸 유도체, 이의 제조방법 및 이를 포함하는 전자수송층
|
|
PE20181197A1
(es)
|
2015-10-14 |
2018-07-23 |
Bristol Myers Squibb Co |
2,4-dihidroxi-nicotinamidas como agonistas del receptor de apelina (apj)
|
|
EP3380970B1
(en)
|
2015-11-24 |
2023-01-04 |
Sanford Burnham Prebys Medical Discovery Institute |
Novel azole derivatives as apelin receptor agonist
|
|
BR112018010720A8
(pt)
|
2015-12-04 |
2019-02-26 |
Bristol Myers Squibb Co |
agonistas do receptor de apelina e métodos de uso
|
|
PE20190258A1
(es)
|
2015-12-09 |
2019-02-25 |
Res Triangle Inst |
Antagonistas del receptor de la apelina (apj) mejorados y usos de los mismos
|
|
ES2854733T3
(es)
|
2015-12-16 |
2021-09-22 |
Bristol Myers Squibb Co |
Heteroarilhidroxipirimidinonas como agonistas del receptor APJ
|
|
TWI744301B
(zh)
|
2016-03-24 |
2021-11-01 |
美商必治妥美雅史谷比公司 |
做為apj促效劑之6-羥基-4-側氧-1,4-二氫嘧啶-5-甲醯胺
|
|
ES2844184T3
(es)
|
2016-06-14 |
2021-07-21 |
Bristol Myers Squibb Co |
4-hidroxi-3-sulfonilpiridin-2(1H)-onas como agonistas del receptor de APJ
|
|
WO2017218633A1
(en)
|
2016-06-14 |
2017-12-21 |
Bristol-Myers Squibb Company |
6-hydroxy-5-(phenyl/heteroarylsulfonyl)pyrimidin-4(1h)-one as apj agonists
|
|
CN110072850B
(zh)
|
2016-10-14 |
2023-07-21 |
百时美施贵宝公司 |
3-磺酰基-5-氨基吡啶-2,4-二醇apj激动剂
|